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S U M M A R Y
We report a case of chronic meningitis due to Mycobacterium chelonae. This organism is a rapidly growing
Mycobacterium (RGM) and can be found worldwide in environmental sources such as soil, dust, and
water. M. chelonae is an uncommon cause of meningitis; the majority of infections caused by this
organism are localized cutaneous or soft tissue infections, and rarely lung infections. The organism is
indistinguishable phenotypically, so we applied PCR based on the rpoB gene sequence followed by
restriction fragment length polymorphism (RFLP) for molecular identiﬁcation. The subsequent
sequencing of RFLP products revealed 99.7% similarity with M. chelonae.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Non-tuberculous mycobacteria (NTM) are common sapro-
phytes in natural ecosystems, such as water, soil, food, and dust,
but in certain circumstances act as opportunistic human patho-
gens.1 These bacteria are characterized and classiﬁed as either slow
or rapid growers. Rapidly growing mycobacteria (RGM), described
by growth within 7 days and improved growth at 30 8C rather than
35 8C, are nearly indistinguishable phenotypically.2 Despite the
fact that mycobacteria belonging to the RGM group rarely cause
disease, there has been an increase in the number of cases of
mycobacterial infections caused by NTM species, especially by
RGM, over the past two decades. They can cause localized
cutaneous infections following trauma, as well as outbreaks of
nosocomial infection and pseudo-outbreaks.3 Surgical site infec-
tions with RGM are most often caused by Mycobacterium fortuitum,
Mycobacterium chelonae, or Mycobacterium abscessus.4
Infections caused by M. chelonae usually involve the skin, bone,
eye, and soft tissue, and rarely the lungs. Although there is a rare
report of endocarditis caused by M. chelonae,5 there has, to date,
been no report of chronic meningitis due to M. chelonae. Patients* Corresponding author. Tel.: +98 611 33300074; fax: +98 611 3332036.
E-mail address: goodarzi200055@yahoo.com (H. Goodarzi).
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1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).with chronic meningitis have the indolent onset of symptoms
compatible with chronic central nervous system infection for at
least 4 weeks and have signs of chronic inﬂammation in the
cerebrospinal ﬂuid (CSF). We report an unusual clinical case of
M. chelonae infection presenting as chronic meningitis.
2. Case report
A 21-year-old woman with clinical signs of fever and loss of
consciousness was referred to the Razi Teaching Hospital
emergency ward in May 2013. Her predominant symptoms
included headache, which had lasted for 6 weeks and had not
responded to analgesics, nausea, vomiting, vertigo, photophobia,
echophonia, and seizures. Physical examinations including
Babinski reﬂex, increase in deep tendon reﬂexes, and Cheyne–
Stokes respiration were positive. A complete blood count (CBC) and
liver function tests (LFT) were normal. Other test results included
lactate dehydrogenase (LDH) of 607 IU/l, Brucella IgG 1.7 U/ml,
Brucella IgM 1.5 U/ml, and an erythrocyte sedimentation rate (ESR)
of 18 mm/h.
With a suspicion of bacterial meningitis, a CSF sample was
taken from the patient and sent for diagnostic tests including cell
count, biochemical tests, direct smear, culture, and PCR. CSF
screening indicated the following results: white blood cell count
(WBC) 40  106/ml (70% lymphocytes and 30% polymorphonuclearciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Primers used for the ampliﬁcation of 360-bp and 723-bp fragments of rpoB and
Myco genes for the identiﬁcation and conﬁrmation of Mycobacterium chelonae
species
Gene Primer sequence Amplicon
size (bp)
RpoB 50 TCAAGGAGAAGCGCTACGA 30 360
50 GGATGTTGATCAGGGTCTGC 30
Myco 50 GGCAAGGTCACCCCGAAGGG 30 723
50 AGCGGCTGCTGGGTGATCATC 30
S. Salmanzadeh et al. / International Journal of Infectious Diseases 27 (2014) 67–6968leukocytes), glucose 22 mg/dl, protein 4240 mg/dl, LDH 975 IU/l,
and adenosine deaminase (ADA) 97 U/l. Direct smear for bacteria
and Venereal Disease Research Laboratory (VDRL) and Wright tests
were all negative. Based on the CSF screening results, the patient was
suspected to have tuberculous meningitis and was admitted to the
infectious diseases ward and placed on treatment with ceftriaxone,
vancomycin, isoniazid, rifampin, streptomycin, pyrazinamide, vita-
min B6, prednisolone, and sodium valproate.
After 2 days, the results of PCR for Mycobacterium tuberculosis
were negative, but blood and CSF cultures on Lowenstein–Jensen
(LJ) medium were positive after 5 days. Thus, a PCR–restriction
fragment length polymorphism (RFLP) analysis based on a 360-bp
fragment of the rpoB gene was used to test for the probable
presence of NTM species; the set of primers used is presented in
Table 1.6 Results of the PCR ampliﬁcation for the rpoB gene were
positive. The PCR product was digested with MspI restriction
enzyme and the digested product was analyzed by electrophore-
sis on a 3.5% agarose gel. The RFLP pattern on gel electrophoresis
was 40, 50, 80, 95, and 105 bp, exactly matching the known
restriction fragment pattern of the reference strain of M. chelonae
(Figure 1).6 Conﬁrmation of M. chelonae was done by DNA
sequencing analysis of a 723-bp fragment of the Myco gene, using
the set of primers listed in Table 1. DNA sequencing revealed
99.7% similarity with M. chelonae for the rpoB gene (GenBank
accession number 35752).
Finally, with the diagnosis of chronic meningitis caused by
M. chelonae, the patient’s treatment was switched to doxycycline
and clarithromycin. Seventy-two hours after treatment with these
drugs, the patient’s fever decreased, her orientation was improved,
and the nausea, vomiting, vertigo, and headache slowly improved.
After 3 weeks of treatment, the patient’s physical condition went
into remission and she was discharged from the hospital, with
treatment to continue for 18–24 months.
3. Discussion
The identiﬁcation of NTM species in general and RGM species
speciﬁcally in clinical samples is of importance, because theFigure 1. Agarose gel electrophoresis of PCR-RFLP analysis products based on the
rpoB gene, digested with MspI for the identiﬁcation of Mycobacterium chelonae. Lane
1, PBR322 digestion with MspI as DNA size marker; lane 2, negative control; lane 3,
Mycobacterium chelonae subsp. chelonae ATCC reference strain; lane 4, patient
sample.therapeutic procedures required for these mycobacteria differ
signiﬁcantly depending on the species present. There are
several reports on the isolation of M. chelonae from patients with
clinical complications. In the immunocompromised patient,
disseminated M. chelonae infection can occur.7,8 However,
Halpern et al. reported a case of disseminated cutaneous
M. chelonae infection in an immunocompetent patient, showing
the potential of the organism to cause infection in a wide range
of hosts.9
Clinical laboratories have commonly used biochemical tests as
phenotypic tests to differentiate RGM species. However, these
methods are time-consuming and identiﬁcation of the organism to
the species level is not always possible.3 In many studies,
molecular techniques including analyses of the 32-kDa protein-
encoding gene, the 16S rRNA gene, dnaJ, recA, sod, and the internal
transcribed spacer 16S–23S rRNA (ITS), have been proposed for the
molecular identiﬁcation of clinical isolates of RGM.10
While soft tissue disease is the most important clinical
manifestation of this organism,3 to date there has been no report
of chronic meningitis due to M. chelonae in the world. Symptoms of
chronic meningitis can wax and wane over weeks and months.
Early symptoms of chronic meningitis include headache, nausea,
and decreased memory and comprehension. When hydrocephalus
complicates indolent meningitis, dementia can be a prominent
ﬁnding. Later symptoms of chronic meningitis include double
vision, decreased vision, or other cranial nerve palsies, unsteady
gait, emesis, and confusion.10
We have reported a case of infection caused by M. chelonae in a
patient with a diagnosis of mycobacterial meningitis who received
primary treatment with anti-tuberculosis drugs. The later appli-
cation of PCR-RFLP revealed M. chelonae to be the unusual cause of
this case of meningitis. To our knowledge, this is the ﬁrst report of
mycobacterial meningitis due to M. chelonae, and our study
provides further evidence of the unusual role of this microorgan-
ism in clinical cases. M. chelonae is resistant to anti-tuberculosis
agents, but clarithromycin and the combination of doxycycline and
amikacin have been shown to be effective against M. chelonae
infections.
In conclusion, M. chelonae should be considered as a possible
etiological pathogen that can be the cause of meningitis. Rapid
molecular tests should be considered for the detection of the
organism so that an appropriate treatment strategy can be
applied.
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